KLK3 and cancer: This point is supported by findings from a retrospective analysis of 1136 prostate patients with cancer across 6 countries in the Middle East and North Africa region, which reported that 78% of the patients were diagnosed only after exhibiting symptoms rather than through routine prostate-specific antigen (PSA) screening.7